Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. - Wikidata - wikimedia - TriplyDB

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

http://www.wikidata.org/entity/Q35065037

about

Emollients and moisturisers for eczema Molecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic Dermatitis Advances in understanding and managing atopic dermatitis Role of Dendritic Cells in the Induction of Lymphocyte Tolerance Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics Change of paradigm: CD8+ T cells as important helper for CD4+ T cells during asthma and autoimmune encephalomyelitis Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches New era of biologic therapeutics in atopic dermatitis The ABC's of managing patients with severe atopic dermatitis The Pathogenetic Effect of Natural and Bacterial Toxins on Atopic Dermatitis Role of Ceramide from Glycosphingolipids and Its Metabolites in Immunological and Inflammatory Responses in Humans Multiple Transcriptome Data Analysis Reveals Biologically Relevant Atopic Dermatitis Signature Genes and Pathways Dendritic Core-Multishell Nanocarriers in Murine Models of Healthy and Atopic Skin Interactive effect of STAT6 and IL13 gene polymorphisms on eczema status: results from a longitudinal and a cross-sectional study.TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis.The biodiversity hypothesis and allergic disease: world allergy organization position statement.Risk factors for eosinophilic esophagitis.Multifactorial Modulation of Food-Induced Anaphylaxis Low prevalence of IgA anti-transglutaminase 1, 2, and 3 autoantibodies in children with atopic dermatitis.Spotlight on dupilumab in the treatment of atopic dermatitis: design, development, and potential place in therapy Atopic dermatitis phenotypes in childhood Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells.An important role of α-hemolysin in extracellular vesicles on the development of atopic dermatitis induced by Staphylococcus aureus Th2 cytokines increase Staphylococcus aureus alpha toxin-induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6)Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.Repositioning drugs for inflammatory disease - fishing for new anti-inflammatory agents.7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice.Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology.Interplay of filaggrin loss-of-function variants, allergic sensitization, and eczema in a longitudinal study covering infancy to 18 years of age.Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention Effects of in utero exposure of C57BL/6J mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin on epidermal permeability barrier development and function Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis Gene expression in the skin of dogs sensitized to the house dust mite Dermatophagoides farinae Staphylococcal and streptococcal superantigen exotoxins The genetics of human skin disease.Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.The absence of a microbiota enhances TSLP expression in mice with defective skin barrier but does not affect the severity of their allergic inflammation Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis.Harmful Effects of Synthetic Surface-Active Detergents against Atopic Dermatitis.Critical role for mast cell Stat5 activity in skin inflammation

P2860

Q24186075-FA4158CA-2A0B-4A67-A786-E7A5888111CE Q26739986-804C0BA9-4025-47F9-A0CE-DA7D903D6B87 Q26766224-58D70876-6944-4CC4-A439-AEF800A48613 Q26779405-4E3B6FB7-F3D1-4C3C-ADD8-261A66E2FE9C Q26799532-BEB080BA-9C00-420F-BD81-4992CE42C2A4 Q26824572-B0D12021-54CD-49E9-A730-A58143766872 Q26852335-2B6AB72B-E323-40D5-BA4F-1B5A164F2FE5 Q27001941-73651077-038D-416E-AD9C-7E44EFEAF351 Q27022610-415E1C00-9408-4263-824E-97DF28274278 Q28068840-B9D30B66-1CCA-4914-9C80-CF43C4E683A3 Q28080555-BCA221E2-4890-4A48-B55E-1D8A2AA1F903 Q28397937-F865BC74-7FF0-4AB7-8D4E-6CA4FB099D30 Q29249083-FF9AB8E4-F7A1-45EF-A7C5-297396F2DF8B Q30541150-9CA5D7CC-012C-4EDC-BC86-AEB0A9B0EB5B Q30587902-68B71A27-608E-41AF-9FB9-0A22EDD2BCA6 Q30624202-B8FCBFCD-94A5-4FAF-B519-2BDF68C1265C Q31170219-8D852AFE-4D15-41B3-8C6E-9F073A629456 Q33690086-419590D3-817B-4F9C-A49E-C70FF1571A84 Q33712334-A07CD64B-CA5B-4289-82C4-1F1F51FE0A3A Q33713754-5E335627-E51A-4C70-B554-05A137EF4E58 Q33776717-58232390-37C0-4BC3-B408-0981A5646D5E Q33815955-D8685B3D-E0CD-4EF9-A784-3A8708990634 Q33854831-F5276672-C085-433E-A6EC-A0A3CF9C4E19 Q33916807-FF6C081C-D32D-4619-98E3-7DD91AA1B8A8 Q34006054-44662217-5688-477D-B4FF-575BA5B151D0 Q34081764-BED9D7C3-8D90-4E28-9BCD-32B67001DC3B Q34109984-A9141E91-60C0-4F02-923F-6A4238298EDF Q34165569-A6D7CC22-39B7-416B-B33D-45770185003B Q34189662-C970BAF6-1750-4012-A886-4353BC67112A Q34266725-DD773785-0A09-4834-8E9D-45765BD298C9 Q34275373-A5541E78-350C-40FB-88B3-B7913C4C45A7 Q34324282-16D78006-FAA5-4ED9-97E4-E1F78AA9C5CA Q34351982-B4EAE162-4B45-416C-9686-97EE0D0AFD97 Q34355243-200FE485-74F6-4BFF-A6DD-DA1B6BCFBF6D Q34355367-61E0D56A-B648-435E-BE0A-65414994E49B Q34531749-F1B4DBCF-308A-41D1-BB3F-CD924A015407 Q34734569-98E7F60A-C24F-44D0-BC9F-EAB02B9C3410 Q34797596-CE602C20-A641-4E8A-9A37-65F693405D19 Q35026030-76F208E6-BF06-4471-9E54-8E7ADFDE5DD7 Q35087816-789519B3-DDDE-440D-9487-5BB507FFEDAA

P2860

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

http://www.wikidata.org/entity/Q35065037

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

@ast

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

@en

type

label

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

@ast

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

@en

prefLabel

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

@ast

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

@en

P1433

Q35065037-CF89D632-90DE-4D8A-8146-5F1CFC968DA9

P1476

Q35065037-7C3EF939-F75C-47F2-803E-ACF6E9CCB278

P2093

Q35065037-4B681489-8BFF-4EE1-920E-831AD352F0AF

Q35065037-5805FD2F-0818-41E4-94D6-AF01F5543C07

P2860

Q35065037-00459DD7-F554-4976-B02F-CBCA25ED21AA

Q35065037-05C349FD-CDE8-4CE8-A0B1-99073AB7706F

Q35065037-067EACDE-A6B8-4E15-8B5D-B4933FB5AF91

Q35065037-08215D72-EFC0-4318-AED9-ABEF75DB9591

Q35065037-0865A522-444B-4E9F-99AE-C90469FD0046

Q35065037-08ACF9F4-10A2-4001-BFBE-1C02D4CC1961

Q35065037-0B0B5D4C-C479-46C0-A4C0-7AFBC0B7CD9E

Q35065037-0B19C01F-B7CF-44D0-A755-33AE9D6F61E0

Q35065037-115F4F0D-03F8-41D2-B913-72A40EF6974A

Q35065037-14B4756C-E81C-4AAB-BB7F-75FCB52822C2

P304

Q35065037-2185EC9C-3447-4B08-BFC9-E1AFB440D175

P31

Q35065037-2DE4BAB7-C2FE-4D5A-8C62-96276F2F4F74

P356

Q35065037-8DDCAD0F-9607-48F3-B099-22EF36F654B6

P433

Q35065037-68ADBB77-992A-4FD6-8915-F2A732C26586

P478

Q35065037-AC7C4ED1-B14D-4C94-B257-D49D6D12BF68

P577

Q35065037-FD0473DA-9060-42B4-8F68-5F6A92286692

P5875

Q35065037-90BAE8E8-40B2-4A21-B2C8-EE94FF827EA0

P698

Q35065037-E68AF22C-E300-4C2F-9877-7EFF49EA21ED

P932

Q35065037-8899D03B-033F-4B5C-A8CD-5217E4A55F80

P356

J.1600-065X.2011.01027.X

P1433

Immunological Reviews

P1476

Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

@en

P2093

Donald Y M Leung

http://www.w3.org/2001/XMLSchema#string

Mark Boguniewicz

http://www.w3.org/2001/XMLSchema#string

P2860

Gene-environment interaction in the onset of eczema in infancy: filaggrin loss-of-function mutations enhanced by neonatal cat exposure

Cellular basis of itch sensation

Antimicrobial peptides and the skin immune defense system

Factors associated with the development of peanut allergy in childhood

Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study

Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis

Genomewide association studies and assessment of the risk of disease

IL-31: a new link between T cells and pruritus in atopic skin inflammation

IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis

P304

233-246

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-065X.2011.01027.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

242

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51228246

http://www.w3.org/2001/XMLSchema#string

P698

21682749

http://www.w3.org/2001/XMLSchema#string

P932

3122139

http://www.w3.org/2001/XMLSchema#string